SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001008848-11-000018
Filing Date
2011-03-01
Accepted
2011-03-01 16:48:07
Documents
16
Period of Report
2010-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 10K form10k2010.htm 10-K 2250533
2 EXHIBIT 21 exhibit21.htm EX-21 2590
3 EXHIBIT 23.1 exhibit23ey.htm EX-23.1 4344
4 EXHIBIT 23.2 exhibit23kpmg.htm EX-23.2 4553
5 EXHIBIT 31.1 exhibit31ceo.htm EX-31.1 15267
6 EXHIBIT 31.2 exhibit31cfo.htm EX-31.2 15134
7 EXHIBIT 32.1 exhibit32ceo.htm EX-32.1 6485
8 EXHIBIT 32.2 exhibit32cfo.htm EX-32.2 7155
9 FORM OF EQUITY AWARD DOCUMENTS exhibit1058.htm EX-10.58 181150
10 chart2010.jpg GRAPHIC 138029
  Complete submission text file 0001008848-11-000018.txt   5803454

Data Files

Seq Description Document Type Size
11 acor-20101231.xml EX-101.INS 641301
12 acor-20101231.xsd EX-101.SCH 15252
13 acor-20101231_cal.xml EX-101.CAL 45900
14 acor-20101231_def.xml EX-101.DEF 16881
15 acor-20101231_lab.xml EX-101.LAB 180432
16 acor-20101231_pre.xml EX-101.PRE 111847
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50513 | Film No.: 11652445
SIC: 2836 Biological Products, (No Diagnostic Substances)